|

TAS-102 (trifluridine and tipiracil, Lonsurf®) Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • Chinese PLA General Hospital1

Indications

  • Biological Therapy1
  • Gastric (Stomach) Cancer1
  • Immunotherapy1
  • Cancer1

Other1 trial

The Safety and Clinical Efficacy of RAK Cell Therapy in Late-stage Gastric Cancer: A Randomized Controlled Trial
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.